Full-day Virtual Seminar: IND Applications for the US FDA (Pharmaceuticals Trai)
Venue: Online Event
|Event Date/Time: Jun 24, 2011||End Date/Time: Jun 24, 2011|
All sponsors of clinical trials in the US for drug and biologics have to first file an Investigational New Drug (IND) application with the FDA containing extensive information in support of the proposed clinical trial. Each year hundreds of new INDs are submitted to the FDA, about half of which are not cleared to proceed with the planned clinical trial within the 30 day review period mostly due to deficiencies in the information provided in the IND. Failure to submit a satisfactory IND could lead to FDA imposing a clinical hold on the clinical trial in turn adding additional expense and delay to a clinical trial.
Who will benefit:
This virtual seminar will provide invaluable assistance to all sponsors, regulatory affairs and project management personnel in the pharmaceutical and biotechnology industry planning to conduct clinical trials under a US IND . Also benefiting would be : Principal Investigators and sub investigators, clinical research scientists, manufacturing personnel, clinical trial personnel, IRB personnel, and preclinical study personnel.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.